摘要
目的:制备载纳豆激酶(NK)的三甲基壳聚糖(TMC)纳米粒(TMC-NK-NPs),并研究其体外释放度。方法:合成季胺化度分别为15%、20%、25%的TMC(即TMC15、TMC20、TMC25),将其与NK自组装形成TMC-NK-NPs。测定TMC-NK-NPs的粒径、多分散系数(PDI)、Zeta电位,筛选TMC;观察并测定最优处方制备的TMC-NK-NPs的形态、包封率、载药量、4℃避光下30 d的稳定性、24 h内的体外累积释放度(Q)及NK活性。结果:采用TMC20所制TMC-NK-NPs的粒径较小[(161.0±4.8)nm],PDI最小(0.204),Zeta电位为(19.2±1.5)m V,呈球形或类球形;包封率为(45.4±1.51)%,载药量为(14.2±0.25)%;30 d内相对稳定;峰值Q_(12 h)为92.3%;NK活性在1 h时就达到最大(76.6%),但随着时间延长,活性降低。结论:成功制得形态圆整、包封率与载药量较高,且具有较好缓释作用的TMC-NK-NPs。
OBJECTIVE: To prepare nattokinase (NK)-loaded tfimethyl chitosan (TMC) nanoparticles (TMC-NK-NPs), and to study its release rate in vitro. METHODS: TMC with different degree of quatemization (15%, 20%, 25%) were synthetized, i.e. TMC15, TMC20, TMC25; those were combined with NK to form TMC-NK-NPs by self-assembly. The particle size, polydispersity index (PDI) and Zeta potential were determined and TCM was screened; the morphology, entrapment efficiency (EE) , drug-loading amount, 30 d stability at 4 ℃ and dark place, 24 h accumulative release rate in vitro (Q) and NK activity of TMC-NK-NPs by optimal formulation were observed and determined. RESULTS: Using TMC20, TMC-NK-NPs were smaller in particle size [(161.0± 4.8) nm], the lowest in PDI (0.204) ; the Zate potential was (19.2 ± 1.5) mV, spherical or spherical-like, EE was (45.4 ± 1.51)%, drug-loading amount was (14.2 ± 0.25)%, stable within 30 d, the peak Q12h was 92.3%. The maximum released activity of NK was 76.6% at 1 h, but then gradually decreased with time. CONCLUSIONS: TMC-NK-NPs are prepared successfully, round and complete with high EE and drug-loading amount, good sustained-release property.
出处
《中国药房》
CAS
北大核心
2016年第31期4403-4406,共4页
China Pharmacy
基金
国家自然科学基金资助项目(No.81373338)
关键词
三甲基壳聚糖
纳豆激酶
纳米粒
体外释放度
制备
Trimethyl chitosan
Nattokinase
Nanoparticles
Release rate in vitro
Preparation